remetinostat
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for remetinostat, covering 2021-01-05 to 2021-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer [Phase 2]